AKRON, Ohio—ACU-Serve, an end-to-end revenue cycle management company, announced the company has signed an agreement with Nymbl Systems, software solutions that aim to deliver better business outcomes for those who enable better health and mobility. The two companies are working together to fill the void for purpose-built automation systems that meet the uniquely complex billing and business management requirements of complex rehab therapy (CRT) providers.
"As the CRT industry continues to grow, we see more of our CRT-oriented customers struggle with business systems that don’t meet their needs—from both a front-end, intake perspective and a back-office, billing perspective," said Jim Knight, CEO of ACU-Serve. "Nymbl brings a fresh approach to addressing the needs of CRT providers, with its roots deeply embedded in the O&P practices where many of the same challenges existed until Nymbl came along.”
CRT providers create, deliver and support specialized medical equipment, devices and services to people with disabilities. These products often require customized, individually tailored solutions to help patients regain or maintain functional independence.
“There has been a large increase of interest amongst our US Rehab members recently," said Tyler Mahncke, vice president of US Rehab. "As billing continues to be difficult and hiring new talent is still a problem, providers are looking to outsource more of their operations and billing is a popular one that we are hearing more and more about. I am excited to hear of the partnership between Nymbl and ACU-Serve.”
“We are seeing tremendous interest among CRT providers for our billing and business management solutions that accommodate for the highly complex and customized processes they have in place," Nymbl COO Chad Feinberg said. "By automating workflows and generating cleaner orders with our solution, CRT providers are able to help patients get what they need faster while also facilitating faster reimbursements. We’re pleased to be working closely with ACU-Serve to meet both the clinical and business needs of the CRT market.”
